Eve & Co Incorporated (EVE.WT) News

Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma

SAN DIEGO, July 23, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the public...

Form 8-K - Current report

Form D - Notice of Exempt Offering of Securities

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it...

Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting

A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring...

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will...

Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis

SAN DIEGO, June 17, 2024 (GLOBE NEWSWIRE) -- Bionano Laboratories, a clinical laboratory services business of...

Form S-3 - Registration statement under Securities Act of 1933

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities